BORIS/CTCFL expression is insufficientfor cancer-germline antigen gene expression and DNA hypomethylationin ovarian cell lines

Cancer immunity

Boquan Jin³  Chajoun Song³  Anna Woloszynska-Read¹  Smitha R. James¹  Adam R. Karpf¹  Kunle Odunsi² 

[1] Department of Pharmacology and Therapeutics,Roswell Park Cancer Institute, Elm and CarltonStreets, Buffalo, NY, 14263, USADepartment of Pharmacology and Therapeutics,Roswell Park Cancer Institute, Elm and CarltonStreets, Buffalo, NY, 14263, USADepartment of Pharmacology and Therapeutics,Roswell Park Cancer Institute, Elm and CarltonStreets, Buffalo, NY, 14263, USA;Department of Immunology, Roswell ParkCancer Institute, Elm and Carlton Streets, Buffalo,NY, 14263, USADepartment of Immunology, Roswell ParkCancer Institute, Elm and Carlton Streets, Buffalo,NY, 14263, USADepartment of Immunology, Roswell ParkCancer Institute, Elm and Carlton Streets, Buffalo,NY, 14263, USA;Department of Immunology, Fourth MilitaryMedical University, Xi'an 710032, ChinaDepartment of Immunology, Fourth MilitaryMedical University, Xi'an 710032, ChinaDepartment of Immunology, Fourth MilitaryMedical University, Xi'an 710032, China

关键词: human;    ovarian cancer;    BORIS;    CT antigens;    gene expression;    DNAmethylation;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown